Clinical Trial Update: Prevention of Graft Reinfection After Liver Transplantation With Anti HCV Monoclonal Antibodies Identified in Chronically Infected Patients or in Patients With Resolved Hepatitis C

View source ↗

Summary

The document outlines a clinical trial investigating whether anti-HCV monoclonal antibodies can prevent graft reinfection after liver transplantation in patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• anti-HCV monoclonal antibodies

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Hepatitis C | Status: UNKNOWN